ANALYTICAL & LABORATORY EQUIPMENT
THECONNECTED LAB
L
ife sciences development has undergone dramatic transformation driven by a need for more connectivity and
visibility across the product lifecycle. Organisations are looking for ways to make data and document sharing across teams easier and streamline manual tasks. With seamless information flowing cross- functionally, the gains in efficiency and insight can help deliver innovations to patients faster and more cost-effectively. Te Lymphoma Academic Research
Organisation (LYSARC), an academic institution devoted to lymphoma clinical research, is starting its journey with a connected technology landscape across clinical data and operations, patient safety and quality management. By standardising processes across product development, the organisation can reduce complexity and streamline how teams work together.
USING A SINGLE PLATFORM TO SPEED RESEARCH LYSARC is the largest European academic institution focused on lymphoma, works with over 2,000 sites and recruits more than 750 patients each
14
www.scientistlive.com
Jim Reilly reveals how a clinical research institution is accelerating its work via the use of connected applications
year. Collaborating with other academic groups, in partnership with pharma companies worldwide, LYSARC aimed to expand its reach with a system that can scale for growth. LYSARC needed to eliminate data silos and reduce manual tasks and process duplication to gain visibility across the organization and speed execution. Te team selected Veeva Development Cloud to build a comprehensive, connected technology foundation that offers higher quality data and streamlines collaboration across clinical, quality, and safety operations.
Te organisation will also encourage its network of partner site investigators to use Veeva SiteVault to make it easier to share information. With one platform across the product ecosystem, LYSARC can ensure alignment with SOPs across stakeholders, ensure high-quality data, and reduce the costs and lead times of clinical trials. “Partnering with Veeva will accelerate our digital transformation for greater scalability and speed in our pursuit to develop innovative lymphoma therapies or improve current therapies,” says Franck Morschhauser, president of LYSARC.
Digital workflows
are shaping the future of lab-based research
“Using Veeva Development Cloud gives us a single connected platform that can free our staff from time-consuming tasks and allow them to focus on what drives us every day: scientific excellence for the benefit of lymphoma patients.”
A UNIFIED PRODUCT DEVELOPMENT LIFECYCLE Organisations such as LYSARC can drive end-to-end processes and evolve how people work by unifying applications across the product lifecycle. Bringing together cross-functional teams enables real-time access to information and seamless data exchange. For example, quality leaders can proactively mitigate risk by running integrated change control and variation management across their quality management system and regulatory operations. Hundreds of global organisations
are unifying and scaling their digital operations across the entire product lifecycle. Labs can bring together applications across functions to drive end-to-end processes for clinical trials, regulatory operations, quality management and patient safety. Tis can improve how sponsors, CROs and
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60
